PTN insider trading

NYSE American Healthcare

PALATIN TECHNOLOGIES INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
398
Last 90 days
0
Buys / sells
10% / 4%
Market cap
$33.15M

About PALATIN TECHNOLOGIES INC

Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.

Company website: palatin.com

PTN insider activity at a glance

FilingIQ has scored 398 insider transactions for PTN since Jul 2, 2014. The most recent filing in our index is dated Dec 30, 2025.

Across the full history, 40 open-market purchases and 16 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on PTN insider trades is 60.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest PTN Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

Frequently asked

How many insider trades does FilingIQ track for PTN?
FilingIQ tracks 398 Form 4 insider transactions for PTN (PALATIN TECHNOLOGIES INC), covering filings from Jul 2, 2014 onwards. 0 of those were filed in the last 90 days.
Are PTN insiders net buyers or net sellers?
Across the full Form 4 history for PTN, 40 transactions (10%) were open-market purchases and 16 (4%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does PTN insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is PTN in?
PALATIN TECHNOLOGIES INC (PTN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $33.15M.

Methodology & sources

Every PTN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.